Internal Medicine, Infectious Disease · New York, NY
NPI
1699805200
Since 2007
Specialty
Internal Medicine, Infectious Disease
Code 207RI0200X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
1111 Amsterdam Ave
New York, NY, 10025
Phone (212) 523-6500
Groups this clinician bills Medicare through
Medicare paid, 2024
$8,625
136 services
Medicare patients, 2024
50
Average age 69
Drug cost, 2024
$4.3M
5,765 prescriptions
Company payments, 2025
$125K
From 6 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Antonio E Urbina was code 99214 (office e&m - established), 97 times for 38 patients. In total Antonio E Urbina billed 136 services in 9 codes, and Medicare paid $8,625.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-05-27.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 97 | 38 | $63.89 | $6,197 |
| 99232 Hospital E&M - Subsequent | Facility | 24 | 11 | $68.31 | $1,639 |
By year: 2022 $13K for 170 services; 2023 $9,496 for 124 services; 2024 $8,625 for 136 services.
Medicare prescription drug claims, 2024
In 2024, the drug Antonio E Urbina prescribed most often to Medicare patients was Biktarvy (Bictegrav/Emtricit/Tenofov Ala), with 436 prescriptions and refills. In total Antonio E Urbina wrote 5,765 Medicare prescriptions that cost $4.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Biktarvy Bictegrav/Emtricit/Tenofov Ala | 436 | 467 | 51 | $1.8M |
| Atorvastatin Calcium Generic | 381 | 523 | 55 | $1,577 |
| Valacyclovir Valacyclovir Hcl | 215 | 252 | 28 | $4,989 |
| Metformin Hcl Generic | 163 | 208 | 24 | $582 |
| Losartan Potassium Generic | 159 | 212 | 25 | $737 |
| Amlodipine Besylate Generic | 157 | 195 | 25 | $479 |
| Descovy Emtricitabine/Tenofov Alafenam | 136 | 136 | 15 | $281K |
| Gabapentin Generic | 110 | 116 | 15 | $702 |
| Tivicay Dolutegravir Sodium | 100 | 100 | 13 | $225K |
| Omeprazole Generic | 98 | 120 | 17 | $331 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 87 | 102 | 18 | $2,528 |
| Rosuvastatin Calcium Generic | 85 | 133 | 16 | $711 |
| Tamsulosin Hcl Generic | 83 | 119 | 13 | $609 |
| Famotidine Generic | 81 | 87 | Under 11 | $333 |
| Vitamin D2 Ergocalciferol (Vitamin D2) | 79 | 95 | 13 | $160 |
Brand drugs: 1,591 claims; generic drugs: 4,131 claims; opioid claims: 27.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Antonio E Urbina $125K ($125K in general payments such as food, travel and fees) from 6 companies. The largest payer was Gilead Sciences, Inc. with $52K.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.